home / stock / enob / enob news

ENOB News and Press, Enochian Biosciences Inc. From 12/03/21

Stock Information
Company Name: Enochian Biosciences Inc.
Stock Symbol: ENOB
Market: NASDAQ
Menu
ENOB ENOB Quote ENOB Short ENOB News ENOB Articles ENOB Message Board
Get ENOB Alerts

News, Short Squeeze, Breakout and More Instantly...
ENOB - Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors

LOS ANGELES, Dec. 03, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, Inventor and Co-Founder of Enochian BioScienc...
ENOB - Shares of Enochian Biosciences Inc. (ENOB) Rise Above Previous 52-Week High

Shares of Enochian Biosciences Inc. (NASDAQ:ENOB) traded today at $13.76, eclipsing its 52-week high. So far today approximately 15.1 million shares have been exchanged, as compared to an average 30-day volume of 182,000 shares. Enochian BioSciences Inc is a biopharmaceutical company. It...

ENOB - Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month

LOS ANGELES, Oct. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the completion of an Investigator Pre-Investigational New Drug (IND) pro...

ENOB - Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity

LOS ANGELES, Oct. 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that Dr. Peter Piot has resigned as Chairperson of the Respiratory Diseases Scienti...
ENOB - Fireside Chat with Enochian BioSciences' CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the upcoming H.C. Wa...

ENOB - Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection

LOS ANGELES, Sept. 27, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the completion of a Pre-Investigational New Drug (IND) process following re...

ENOB - Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference

LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be making a company presentation to investors at the upcoming H.C. Wainwright Global Life Sc...
ENOB - Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences' Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants

LOS ANGELES, Aug. 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced the appointment of internationally renowned scientists and public health leaders to a S...

ENOB - Distinguished Scientific and Clinical Leader to Join Enochian BioSciences' Hepatitis B Cure Scientific Advisory Board

LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that the renowned Dr. Anna Suk-Fong Lok, MD, has joined the Scientific Advisory Boa...

ENOB - Enochian BioSciences picks Hon. Dr. Mark Dybul as CEO

Enochian BioSciences (ENOB) appointed Honorable Mark Dybul, M.D. as CEO; he has served as Executive Vice-Chair of the Board since January 2019.He was a principal architect and ultimately the head of the U.S. President’s Emergency Plan for AIDS Relief; he went o...
Previous 10 Next 10